• 11β-HSD1, Notch, and NK Cells in Liver Fibrosis

  2026-09-17

  A 2025 mouse study shows that inhibiting 11β-HSD1 reduces thioacetamide-induced liver fibrosis through coordinated suppression of Notch signaling and enhancement of natural killer cell responses. The findings connect intrahepatic cortisol regulation with hepatic stellate cell activity and immune-mediated clearance, while also defining important limits for translation to MASLD and MASH research.

• Carbapenemase Transmission in Enterobacter cloacae

  2026-09-17

  A 2025 BMC Microbiology study integrated gene localization, antimicrobial susceptibility, conjugation, mobile-element analysis, and strain typing to investigate carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong. Its central finding was that blaNDM-1 was frequently plasmid-associated and highly transferable, linking multidrug resistance with both horizontal and clonal dissemination risks.

• IWR-1-endo: Wnt Signaling Inhibitor Workflows

  2026-09-16

  IWR-1-endo enables controlled pathway perturbation across colorectal cancer, stem-cell, regeneration, and exploratory cardiac assays. This practical guide links Axin-complex stabilization to reproducible dosing, morphology profiling, β-catenin readouts, and troubleshooting.

• Meropenem Workflows for Resistance Research

  2026-09-16

  Build reproducible Meropenem assays for susceptibility testing, resistance dynamics, and Gram-negative infection models. This workflow-centered guide connects PBP biology with plasmid-transmission analysis, formulation comparisons, and septicemia treatment research while keeping exploratory findings separate from clinical interpretation.

• 2,2,2-Trichloroethanol for Protein Analysis

  2026-09-15

  Use 2,2,2-Trichloroethanol as a flexible protein analysis reagent for electrophoresis, assay development, and molecular biology research. Its water, ethanol, and DMSO solubility supports practical screening, while DAT-imaging research shows why orthogonal protein-level validation matters in translational workflows.

• Phosbind Acrylamide for Mechanism-Driven Phospho Assays

  2026-09-15

  Phosbind Acrylamide enables antibody-independent protein phosphorylation analysis by converting phosphate-dependent binding into an SDS-PAGE mobility readout. This article explains how to use the reagent strategically when studying EV71 host-factor biology, while distinguishing protein phosphorylation from PI4P lipid signaling.

• Annexin A7, TIA1 Trafficking, and Axonal Protection

  2026-09-14

  The reference study identifies Annexin A7 as a calcium-sensitive regulator that helps couple TIA1-containing ribonucleoprotein granules to cytoplasmic dynein for retrograde axonal transport. Its findings connect impaired RNA granule trafficking with pathological TIA1 aggregation, axonopathy, and neurodegeneration, providing a mechanistic framework for studying how transport failure contributes to disease.

• Septin4, VHL, and HIF-1α in Cardiac Hypoxia

  2026-09-14

  The reference study identifies HIF-1α as a previously unrecognized Septin4-interacting protein in hypoxia-stressed cardiomyocytes. Its data indicate that Septin4 strengthens VHL-dependent HIF-1α degradation, reducing a protective hypoxic response and intensifying apoptosis, while also defining experimental considerations for studying oxygen-sensing pathways.

• Phenothiazines, ROS, and Autophagy in Macrophage Defense

  2026-09-13

  Qiu and colleagues show that phenothiazines strengthen macrophage antibacterial activity by increasing lysosomal function, autophagy, and reactive oxygen species accumulation. Inhibitor and scavenger experiments, together with an in vivo Salmonella Typhimurium model, support a host-directed mechanism that is especially relevant to intracellular bacterial infections, while leaving compound-specific and translational questions open.

• SM-102: Reliable LNP Workflows for Cell Assays

  2026-09-12

  Learn how SM-102 (SKU C1042) can support controlled mRNA delivery experiments and more interpretable cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers solvent compatibility, controls, formulation handling, data interpretation, and practical vendor selection.

• Ciprofloxacin in Applied Research Workflows

  2026-09-11

  Ciprofloxacin supports reproducible antibacterial, resistance, and mechanism-focused experiments when solubility, exposure, and controls are managed carefully. This guide also translates a 2026 nanotheranostic study into practical assay choices without overstating the compound’s oncology evidence.

• Oxaliplatin: DNA Damage and Cancer Models

  2026-09-11

  Oxaliplatin is a platinum-based chemotherapeutic agent that forms DNA adducts and supports apoptosis induction via DNA damage in cancer research. Its established colorectal cancer use, preclinical combination evidence, formulation constraints, and model-specific limitations make it useful for cancer chemotherapy and resistance studies.

• Meropenem as a Benchmark for Infection Models

  2026-09-10

  Meropenem is a β-lactam antibiotic carbapenem with an unusually broad antibacterial profile. This article reframes it as a mechanistic benchmark for designing infection, exposure-response, formulation, and resistance assays rather than as a routine protocol reagent.

• From Vaccine Signal to Translational IgG Evidence

  2026-09-10

  Variant-aware vaccine development depends on more than antigen design: it requires assay architectures that translate immune responses into reproducible evidence. This thought-leadership article connects preclinical SARS-CoV-2 vaccine findings with practical human IgG detection using the HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody.

• Thermal-Protective Hydrogel for Tumor Ablation

  2026-09-09

  The reference study introduces MR@CaP@HA, an injectable hydrogel that combines local thermal insulation with pH- and glutathione-responsive delivery of mitoxantrone and Resiquimod (R-848). By protecting adjacent tissue while promoting immunogenic cell death and innate immune activation, the platform improved residual-tumor control after radiofrequency ablation and provides a material-based strategy for cancer immunotherapy research.

8298 records 1/554 page Next 12345 下5页 Last page